Vivos Therapeutics VVOS
NASDAQ VVOS
$0.14 +0.01 (+3.86%)
As of: Oct 20, 2026 · 3:59 PM EDT

Vivos Therapeutics (VVOS) Long-Term Debt Repayments (2021 - 2026)

Updated

Vivos Therapeutics' Long-Term Debt Repayments was $14,000 in Q2 2026, unchanged from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Long-Term Debt Repayments (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vivos Therapeutics' Long-Term Debt Repayments was $39,000 through Jun 30, 2026; for FY2025, it was $28,000.

  • Long-Term Debt Repayments shows a five-year compound annual growth rate of -17.9% (FY2020 to FY2025).
  • In earlier years, Long-Term Debt Repayments was $25,000 in FY2021 (-66.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn -
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn 1.41 Bn
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn -
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn -
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn -
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn -
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn -
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn 2.00 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn -
10 Vivos Therapeutics 2.48 Mn -6.56 Mn 2.95 Mn 14,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14,000.00
Mar 31, 2026 14,000.00
Dec 31, 2025 11,000.00
Mar 31, 2021 25,000.00
API Access

Vivos Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VVOS&period=max&api_key=YOUR_API_KEY